162 related articles for article (PubMed ID: 12605231)
21. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.
Lucas PJ; Negishi I; Nakayama K; Fields LE; Loh DY
J Immunol; 1995 Jun; 154(11):5757-68. PubMed ID: 7751626
[TBL] [Abstract][Full Text] [Related]
22. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
23. T cell activation: you can't get good help.
Linsley PS
Nat Immunol; 2001 Feb; 2(2):139-40. PubMed ID: 11175808
[No Abstract] [Full Text] [Related]
24. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
[TBL] [Abstract][Full Text] [Related]
25. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
[TBL] [Abstract][Full Text] [Related]
26. Local immunomodulation to promote co-stimulatory blockade.
Chahine AA; Stoeckert C; Lau HT
Clin Transplant; 1995 Jun; 9(3 Pt 2):215-8. PubMed ID: 7670166
[No Abstract] [Full Text] [Related]
27. Positive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80.
Boulougouris G; McLeod JD; Patel YI; Ellwood CN; Walker LS; Sansom DM
J Immunol; 1998 Oct; 161(8):3919-24. PubMed ID: 9780158
[TBL] [Abstract][Full Text] [Related]
28. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
[TBL] [Abstract][Full Text] [Related]
29. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
Egen JG; Kuhns MS; Allison JP
Nat Immunol; 2002 Jul; 3(7):611-8. PubMed ID: 12087419
[TBL] [Abstract][Full Text] [Related]
30. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.
Kearney ER; Walunas TL; Karr RW; Morton PA; Loh DY; Bluestone JA; Jenkins MK
J Immunol; 1995 Aug; 155(3):1032-6. PubMed ID: 7543510
[TBL] [Abstract][Full Text] [Related]
31. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
[TBL] [Abstract][Full Text] [Related]
32. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
[TBL] [Abstract][Full Text] [Related]
33. Novel costimulators in the immune gene therapy of cancer.
Galea-Lauri J; Farzaneh F; Gäken J
Cancer Gene Ther; 1996; 3(3):202-14. PubMed ID: 8725885
[TBL] [Abstract][Full Text] [Related]
34. Ligation of the CD2 co-stimulatory receptor enhances IL-2 production from first-generation chimeric antigen receptor T cells.
Cheadle EJ; Rothwell DG; Bridgeman JS; Sheard VE; Hawkins RE; Gilham DE
Gene Ther; 2012 Nov; 19(11):1114-20. PubMed ID: 22130449
[TBL] [Abstract][Full Text] [Related]
35. Finally, CTLA4Ig graduates to the clinic.
Sayegh MH
J Clin Invest; 1999 May; 103(9):1223-5. PubMed ID: 10225963
[No Abstract] [Full Text] [Related]
36. CD2 molecules redistribute to the uropod during T cell scanning: implications for cellular activation and immune surveillance.
Tibaldi EV; Salgia R; Reinherz EL
Proc Natl Acad Sci U S A; 2002 May; 99(11):7582-7. PubMed ID: 12032326
[TBL] [Abstract][Full Text] [Related]
37. The role of CTLA-4 in immune regulation.
Verhagen J; Sabatos CA; Wraith DC
Immunol Lett; 2008 Jan; 115(1):73-4. PubMed ID: 18035425
[No Abstract] [Full Text] [Related]
38. Structure and expression of genes involved in T lymphocyte recognition and activation.
Owen MJ; Crumpton MJ; Dunne J; Krissansen G; Lamb J; Sewell W
Adv Exp Med Biol; 1987; 225():223-31. PubMed ID: 2899379
[No Abstract] [Full Text] [Related]
39. Stimulation by superantigen.
Cohen CJ; Duke RC; Sellins KS
Nature; 1991 Jul; 352(6332):199-200. PubMed ID: 1857413
[No Abstract] [Full Text] [Related]
40. Sweet 'n' sour: the impact of differential glycosylation on T cell responses.
Daniels MA; Hogquist KA; Jameson SC
Nat Immunol; 2002 Oct; 3(10):903-10. PubMed ID: 12352967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
